PRRT2 and neoplasm: Since the PKC family plays a key role in cell proliferation and vasculature formation that is critical for tumor growth and has been identified as a direct target of “tumor-promoting” phorbol esters, inhibition of the PKC signaling pathway has long been a target of anti-cancer therapy [56].